Medtech companies directory 2026

    Medical Device Companies in India

    Indian hospital technology is a three-layer market that a single “India TAM” slide erases: CDSCO licence on the file, a GeM or AIIMS rate-contract on the public dock, and a private chain such as Apollo that buys like a Gulf account once the licence is in hand.

    Poly Medicure, Hindustan Syringes & Medical Devices, Trivitron, Skanray, Meril, Transasia and BPL Medical Technologies are the domestic names already on government rate contracts and on private-chain vendor lists. CDSCO’s medical-device rules (the 2017 framework and the licence waves that followed) turned a loosely notified sector into a registrant-and-importer market. AIIMS and other central institutes still set the public specification many state tenders copy. Apollo’s central procurement is the private benchmark; other chains (Fortis, Max, Manipal, Narayana, Medanta) run their own capital committees. Multinational imaging and implant houses keep Indian subsidiaries and still need a local importer or C&F for many SKUs. BioNixus studies those named licences, rate contracts and chain vendor codes.

    Updated September 2026 · CDSCO — Central Drugs Standard Control Organisation, medical device licensing as of September 2026 · 16 named accounts

    CDSCO

    Central Drugs Standard Control Organisation — medical-device licensing authority

    GeM / AIIMS

    Public rate-contract and institute-tender path most central-hospital volume still rides

    PLI

    Production-linked incentive that pulled more device assembly onto Indian factory floors

    Apollo

    Private-chain procurement benchmark other groups are measured against in fieldwork

    Named accounts

    Top medical device companies in India

    Public, well-known names BioNixus studies at account and SKU level. This is an editorial snapshot, not an endorsement or a market-share ranking. Cross-checked against CDSCO — Central Drugs Standard Control Organisation, medical device licensing (as of 2026-09-05).
    #CompanyHQ
    01CDSCO medical devicesNew Delhi
    02AIIMS / central institute and GeM tendersNew Delhi / GeM
    03Apollo Hospitals — central procurementChennai / Hyderabad
    04Poly MedicureFaridabad
    05Hindustan Syringes & Medical Devices (HMD)Faridabad
    06Trivitron HealthcareChennai
    07Skanray TechnologiesMysuru
    08MerilVapi
    09Transasia Bio-Medicals (Erba)Mumbai
    10BPL Medical TechnologiesBengaluru
    11GE HealthCare IndiaBengaluru
    12Siemens Healthineers IndiaBengaluru / Mumbai
    13Medtronic IndiaMumbai / Delhi NCR
    14State medical-services corporations (TNMSC, KMSCL and peers)State capitals
    15Indian C&F and hospital distributorsDelhi NCR / Mumbai / Chennai
    16Fortis / Max / Narayana — chain procurement desksDelhi NCR / Bengaluru

    Primary research

    These are the medical device companies accounts we study in India

    Need account-level or SKU-level data for a brand in India? BioNixus runs primary fieldwork — brand vs competitors, including the channels a dashboard averages away. Proposal ready within 48 hours of a brief.

    Planning research in India?

    Primary research, market access & HEOR. Proposals within 48 hours.

    Top market research companies in India (2026)

    How the market is structured

    Licence, rate contract, chain vendor code

    A device that will be used in an Indian public hospital needs a CDSCO medical-device licence — import or manufacture — held by an Indian legal entity, plus a place on a GeM catalogue, an AIIMS or other institute rate contract, or a state-corporation tender (TNMSC, KMSCL, Odisha, Rajasthan and the others). That is a different object from a US 510(k) or an EU MDR certificate that the importer waves at a private biomedical engineer. Capital equipment for AIIMS, ESIC, railway and defence hospitals is specified by the institute’s stores and the user department, then opened as a tender that domestic preference language now shapes. Skanray and BPL fight for mid-tier monitoring and imaging seats on those lots; GE HealthCare India and Siemens Healthineers India still win the high-end teaching-hospital rooms. Consumables — syringes, IV cannulae, sutures, rapid tests — are volume sports: Hindustan Syringes and Poly Medicure live on rate contracts; Transasia and Trivitron live on analyser-plus-reagent placements in public and private labs. Meril has used domestic manufacturing and clinical programmes to put stents and structural-heart devices onto Indian cath-lab shelves beside the import majors. Apollo’s central procurement, and the equivalent desks at Fortis, Max and Narayana, buy capital on committee cycles and consumables on vendor-code contracts that a new importer will not enter by sending a Delhi hotel meeting request. State corporations remain a separate map: a Tamil Nadu win does not stock a Rajasthan dock. BioNixus reconstructs the named CDSCO licence, the named rate contract and the named chain vendor code before an India volume number is treated as real.

    Local

    Faridabad, Vapi, Mysuru, Chennai and Bengaluru manufacturers already on GeM, AIIMS-style rate contracts and private-chain vendor lists.

    • Poly Medicure
    • Hindustan Syringes & Medical Devices (HMD)
    • Trivitron Healthcare
    • Skanray Technologies
    • Meril
    • Transasia Bio-Medicals (Erba)
    • BPL Medical Technologies

    Multinational

    Bengaluru and Mumbai multinational seats that win teaching-hospital rooms and still share district invoices with C&F houses.

    • GE HealthCare India
    • Siemens Healthineers India
    • Medtronic India

    Regional

    State-corporation winners and city C&F houses that hold the licence and the last-mile when a subsidiary does not invoice the dock.

    Distributors & service partners

    CDSCO as the licence, GeM and AIIMS as the public specification, Apollo and peer chains as the private vendor-code door.

    • CDSCO medical devices
    • AIIMS / central institute and GeM tenders
    • Apollo Hospitals — central procurement
    • State medical-services corporations (TNMSC, KMSCL and peers)
    • Indian C&F and hospital distributors
    • Fortis / Max / Narayana — chain procurement desks

    What is moving

    What is moving the medical device market in India

    CDSCO licence waves and importer accountability

    Classification waves turned informal import books into licensed files; a hospital store now asks for the CDSCO number before it opens a new vendor code.

    PLI and domestic preference on public lots

    Production-linked incentive and make-in-India language on GeM and institute tenders have pulled Skanray, BPL, Meril and Poly Medicure onto lots import houses used to treat as automatic.

    Private-chain capital cycles

    Apollo, Fortis, Max, Manipal and Narayana refresh imaging and OR suites on committee calendars that a Delhi hotel meeting will not unlock.

    State-corporation fragmentation

    TNMSC, KMSCL and their peers reset consumable prices on their own clocks; a single AIIMS rate contract is not a national public win.

    BioNixus fieldwork

    How BioNixus studies medical device companies in India

    The accounts above are the ones our field teams and analysts work with. What a brand team typically commissions from us in India:
    • CDSCO licence-to-SKU traces so the number on the file matches the carton a district store unwraps.
    • AIIMS and named state-corporation rate-contract reconstructions (TNMSC, KMSCL and peers) treated as separate buyers.
    • Apollo, Fortis, Max and Narayana vendor-code and capital-committee interviews on different calendars.
    • Teaching-hospital versus district installed-base walks for imaging and monitoring, so a Bengaluru multinational seat is not counted as national cover.

    Healthcare market research in India

    Questions

    Frequently Asked Questions

    How are medical devices licensed in India?

    CDSCO issues import or manufacturing licences under the medical-device rules. An Indian legal entity holds the file. Hospitals and GeM catalogues now ask for that number before they open a vendor code.

    Who buys equipment for Indian public hospitals?

    AIIMS and other central institutes run their own tenders. GeM is the catalogue many central and state buyers raise against. State medical-services corporations run separate rate contracts.

    How does Apollo procurement work for devices?

    A central desk issues vendor codes and runs capital committees. Other chains copy the structure but not the calendar. A new importer is not on the list until that desk says so.

    Which Indian manufacturers belong on a launch brief?

    Poly Medicure and HMD for consumables, Trivitron and Transasia for IVD, Skanray and BPL for electromedical, Meril for stents and implants — each already on public or chain lists.

    What does BioNixus study on Indian device accounts?

    CDSCO licence-to-SKU traces, AIIMS and state-corporation rate-contract reconstructions, Apollo and peer-chain vendor-code interviews, and district-versus-teaching-hospital installed-base walks.

    Is the directory an Indian market-share table?

    No. Names appear because they recur in BioNixus hospital and laboratory fieldwork; sequence is by role, not by turnover.

    Sources

    Data sources & methodology

    This directory aggregates publicly available company and channel facts — filings, brand sites, and BioNixus fieldwork in India. It is an editorial snapshot of the accounts we study, not a share ranking and not a substitute for NielsenIQ, IQVIA, or another syndicated feed.

    Primary register: CDSCO — Central Drugs Standard Control Organisation, medical device licensing, consulted 2026-09-05. Company classification (Local / MNC / Regional / distributors & service partners) reflects ownership and role in India, not size.

    • CDSCO medical-device rules, classification and licence notices, consulted 2026
    • GeM catalogue and AIIMS / central-institute tender notices
    • Poly Medicure, HMD, Trivitron, Skanray, Meril, Transasia and BPL published company descriptions
    • BioNixus India hospital, laboratory and state-corporation fieldwork, 2023–2026

    BioNixus sells account-level and SKU-level primary research that complements those subscriptions. For a scoped proposal, contact the team or use the form below. Email admin@bionixus.com.

    48-hour proposal

    Need device-level competitive data in India?

    Installed base, procedure volumes, surgeon preference and tender outcomes by hospital — fielded across public and private operators.

    Planning research in India?

    Primary research, market access & HEOR. Proposals within 48 hours.